DXCM R&D Expenses
Dexcom · R&D Expenses
DXCM R&D Expenses
Latest reported$604.00Mperiod ending
DXCM TTM R&D Expenses ($26.40M → $604.00M)
TTM R&D Expenses
High-resolution chart · PNG
DXCM r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 604,000,000 | |
| 599,200,000 | |
| 599,100,000 | |
| 590,400,000 | |
| 568,300,000 | |
| 556,100,000 | |
| 552,400,000 | |
| 549,000,000 | |
| 545,000,000 | |
| 528,300,000 | |
| 505,800,000 | |
| 486,000,000 | |
| 464,900,000 | |
| 467,300,000 | |
| 484,200,000 | |
| 604,800,000 | |
| 623,300,000 | |
| 630,700,000 | |
| 604,200,000 | |
| 486,500,000 | |
| 445,400,000 | |
| 396,200,000 | |
| 359,900,000 | |
| 319,500,000 | |
| 298,500,000 | |
| 287,600,000 | |
| 273,500,000 | |
| 470,000,000 | |
| 453,400,000 | |
| 431,600,000 | |
| 417,400,000 | |
| 190,800,000 | |
| 184,000,000 | |
| 182,100,000 | |
| 185,400,000 | |
| 180,400,000 | |
| 181,000,000 | |
| 172,000,000 | |
| 156,100,000 | |
| 140,900,000 | |
| 161,800,000 | |
| 149,900,000 | |
| 137,500,000 | |
| 130,600,000 | |
| 84,300,000 | |
| 74,700,000 | |
| 69,400,000 | |
| 60,400,000 | |
| 53,700,000 | |
| 50,000,000 | |
| 44,800,000 | |
| 40,905,000 | |
| 39,687,000 | |
| 39,085,000 | |
| 39,500,000 | |
| 40,027,000 | |
| 37,676,000 | |
| 34,194,000 | |
| 30,747,000 | |
| 28,417,000 | |
| 26,347,000 | |
| 24,756,000 | |
| 23,227,000 | |
| 20,497,000 | |
| 17,832,000 | |
| 15,862,000 | |
| 14,294,000 | |
| 14,693,000 | |
| 16,615,000 | |
| 17,957,000 | |
| 19,629,000 | |
| 19,455,000 | |
| 17,708,000 | |
| 16,939,000 | |
| 16,131,000 | |
| 15,663,888 | |
| 16,627,045 | |
| 17,960,464 | |
| 19,419,549 | |
| 26,435,537 | |
| 26,844,373 | |
| 26,461,672 | |
| 26,402,664 |